VAV Lifesciences inks deal to supply synthetic phospholipids for m-RNA based COVID-19 vaccines
The company has already initiated a commercial supply of phospholipids for large-scale vaccine manufacturing through its facility…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.